West Financial Advisors LLC Invests $49,000 in The Cooper Companies, Inc. (NASDAQ:COO)

West Financial Advisors LLC purchased a new stake in The Cooper Companies, Inc. (NASDAQ:COO) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 533 shares of the medical device company’s stock, valued at approximately $49,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Ashton Thomas Securities LLC bought a new stake in shares of Cooper Companies in the 3rd quarter valued at approximately $25,000. Covestor Ltd raised its holdings in Cooper Companies by 144.9% during the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after buying an additional 200 shares during the period. Brown Brothers Harriman & Co. lifted its position in Cooper Companies by 191.0% in the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after buying an additional 275 shares during the last quarter. Friedenthal Financial purchased a new position in Cooper Companies during the third quarter worth $50,000. Finally, Cromwell Holdings LLC bought a new position in Cooper Companies during the third quarter valued at $52,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analyst Ratings Changes

COO has been the subject of several analyst reports. Citigroup lowered their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a report on Friday, December 6th. Morgan Stanley dropped their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Friday, December 6th. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Wells Fargo & Company raised their price target on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Stock Up 1.8 %

NASDAQ:COO opened at $90.68 on Thursday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38. The company has a 50-day moving average of $97.24 and a 200 day moving average of $98.95. The firm has a market cap of $18.10 billion, a PE ratio of 46.50, a price-to-earnings-growth ratio of 2.29 and a beta of 0.99.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating the consensus estimate of $1.00 by $0.04. The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company’s quarterly revenue was up 9.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.87 EPS. As a group, research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.